Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China · Delayed Price · Currency is CNY 28.89
+0.49 (1.73%)
May 8, 2026, 3:04 PM CST
SHE:300753 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 345.51 | 342.02 | 402.3 | 420.79 | 323.38 | 460.72 |
Other Revenue | - | - | 1.5 | 1.38 | 0.43 | 0.49 |
| 345.51 | 342.02 | 403.8 | 422.17 | 323.81 | 461.21 | |
Revenue Growth (YoY) | -9.29% | -15.30% | -4.35% | 30.38% | -29.79% | 4.09% |
Cost of Revenue | 106.36 | 107.94 | 127.74 | 145.71 | 163.82 | 166.33 |
Gross Profit | 239.15 | 234.07 | 276.06 | 276.46 | 159.99 | 294.88 |
Selling, General & Admin | 216.49 | 227.85 | 231.61 | 228.59 | 207.17 | 199.73 |
Research & Development | 41.54 | 40.56 | 33.28 | 36.55 | 34.95 | 43.98 |
Other Operating Expenses | -6.34 | -8.45 | -13.03 | -8.28 | -2.53 | -3.78 |
Operating Expenses | 251.69 | 259.96 | 258.06 | 264.8 | 240.71 | 246.76 |
Operating Income | -12.54 | -25.89 | 18 | 11.66 | -80.72 | 48.12 |
Interest Expense | - | - | -3.07 | -3.04 | -2.47 | -1.13 |
Interest & Investment Income | 0.86 | 1.55 | 1.98 | 2.27 | 3.51 | 4.46 |
Currency Exchange Gain (Loss) | - | - | 0 | - | - | - |
Other Non Operating Income (Expenses) | 0.27 | -0.26 | -0.06 | -0.06 | -0.06 | -0.1 |
EBT Excluding Unusual Items | -11.85 | -24.6 | 16.86 | 10.84 | -79.75 | 51.35 |
Impairment of Goodwill | - | - | - | - | -16.16 | - |
Gain (Loss) on Sale of Investments | - | - | -1.38 | -1.44 | - | - |
Gain (Loss) on Sale of Assets | 0.12 | 0.12 | 3.59 | 0.01 | -0.02 | - |
Asset Writedown | -1.33 | -1.61 | -0 | -0 | -0.01 | -0 |
Other Unusual Items | - | - | 2.11 | 4.41 | 5.24 | 3.95 |
Pretax Income | -13.06 | -26.08 | 21.17 | 13.81 | -90.71 | 55.3 |
Income Tax Expense | 0.43 | 0.75 | 10.27 | 5.36 | -14.59 | 1.98 |
Earnings From Continuing Operations | -13.49 | -26.83 | 10.89 | 8.45 | -76.12 | 53.32 |
Minority Interest in Earnings | 2.73 | 2.81 | -0.09 | -0.17 | 0.14 | 0.75 |
Net Income | -10.76 | -24.02 | 10.8 | 8.28 | -75.98 | 54.06 |
Net Income to Common | -10.76 | -24.02 | 10.8 | 8.28 | -75.98 | 54.06 |
Net Income Growth | - | - | 30.48% | - | - | -44.24% |
Shares Outstanding (Basic) | 126 | 126 | 126 | 126 | 126 | 126 |
Shares Outstanding (Diluted) | 126 | 126 | 126 | 126 | 126 | 126 |
Shares Change (YoY) | -0.06% | -0.00% | 0.03% | -0.05% | -0.00% | 0.00% |
EPS (Basic) | -0.09 | -0.19 | 0.09 | 0.07 | -0.60 | 0.43 |
EPS (Diluted) | -0.09 | -0.19 | 0.09 | 0.07 | -0.60 | 0.43 |
EPS Growth | - | - | 30.44% | - | - | -44.24% |
Free Cash Flow | 7.55 | -6.1 | 5.45 | -54.07 | -48.76 | -21.31 |
Free Cash Flow Per Share | 0.06 | -0.05 | 0.04 | -0.43 | -0.39 | -0.17 |
Dividend Per Share | - | - | 0.065 | 0.065 | - | - |
Gross Margin | 69.22% | 68.44% | 68.37% | 65.49% | 49.41% | 63.94% |
Operating Margin | -3.63% | -7.57% | 4.46% | 2.76% | -24.93% | 10.43% |
Profit Margin | -3.12% | -7.02% | 2.67% | 1.96% | -23.46% | 11.72% |
Free Cash Flow Margin | 2.18% | -1.78% | 1.35% | -12.81% | -15.06% | -4.62% |
EBITDA | 3.71 | -10.11 | 31.86 | 24.33 | -66.97 | 60.9 |
EBITDA Margin | 1.07% | -2.96% | 7.89% | 5.76% | -20.68% | 13.21% |
D&A For EBITDA | 16.25 | 15.77 | 13.86 | 12.67 | 13.76 | 12.78 |
EBIT | -12.54 | -25.89 | 18 | 11.66 | -80.72 | 48.12 |
EBIT Margin | -3.63% | -7.57% | 4.46% | 2.76% | -24.93% | 10.43% |
Effective Tax Rate | - | - | 48.53% | 38.81% | - | 3.58% |
Revenue as Reported | - | - | 403.8 | 422.17 | 323.81 | 461.21 |
Advertising Expenses | - | - | 24.34 | 31.35 | 27.28 | 16.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.